Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - AVRA Medical Robotics, Inc.s109199_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - AVRA Medical Robotics, Inc.s109199_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - AVRA Medical Robotics, Inc.s109199_ex31-1.htm
10-Q/A - 10-Q/A - AVRA Medical Robotics, Inc.s109199_10qa.htm

Exhibit 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER   

PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED 

 PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

  

In connection with this Quarterly Report on Form 10-Q/A Amendment No. 1 to Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 of AVRA Medical Robotics, Inc., a Florida corporation (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, A. Christian Schauer, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

1.          The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

  

2.          The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: February 28, 2018 AVRA MEDICAL ROBOTICS, INC.
     
  By: /s/ A. Christian Schauer
    A. Christian Schauer, Chief Financial Officer
    (Principal Financial and Accounting Officer)